Synthorx, Inc. was a fully owned subsidiary of Sanofi with THOR-707, additional pre-clinical assets, and a platform complementing Sanofi’s oncology and immunology research.
Also known as
Synthorx
Relationship register
3 documented relationships
Documented relationships
3 documented relationships
Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.Detailed register